Multidisciplinary considerations in the maintenance treatment of poly(ADP-ribose) polymerase inhibitors for homologous recombination-proficient, advanced-stage epithelial ovarian cancer
- PMID: 36369877
- DOI: 10.3322/caac.21764
Multidisciplinary considerations in the maintenance treatment of poly(ADP-ribose) polymerase inhibitors for homologous recombination-proficient, advanced-stage epithelial ovarian cancer
References
REFERENCES
-
- Randall LM, Bothuri B, Swisher EM, et al. Multidisciplinary summit on genetics services from women with gynecologic cancers: a Society of Gynecologic Oncology White Paper. Gynecol Oncol. 2017;146:217-224.
-
- Society of Gynecologic Oncology (SGO). SGO Clinical Practice Statement: Genetic testing for ovarian cancer. SGO; 2014. https://www.sgo.org/resources/genetic-testing-for-ovarian-cancer/
-
- Siegel RL, Miller KD, Fuchs AD, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. doi:10.3322/caac.21654
-
- Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BAJ. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynecol. 1998;105(5):493-499. doi:10.1111/j.1471-0528.1998.tb10148.x
-
- Norquist BM, Harrell MI, Brady MF, et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2(4):482-490. doi:10.1001/jamaoncol.2015.5495
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical